Skip to main content
TrialFinder
TrialFinder is for informational purposes only and does not provide medical advice. Always talk to your doctor about whether a trial is right for you.
RECRUITINGINTERVENTIONAL

Lung Ultrasound for the Detection of Volume Overload in Patients With Severe Preeclampsia

Usefulness of Lung Ultrasound for the Detection of Volume Overload in Patients With Severe Preeclampsia

Important: This information is not medical advice. Talk to your doctor about whether a clinical trial is right for you.

About This Trial

This research aims to evaluate the usefulness of lung ultrasound (LUS) for detecting and monitoring fluid overload in patients with severe preeclampsia. Severe preeclampsia is a leading cause of maternal death and illness worldwide, often causing fluid buildup that can lead to a serious complication called pulmonary edema, especially after delivery. The study will be a prospective, longitudinal observational study with a diagnostic validation component. It will involve patients with a diagnosis of severe preeclampsia who meet specific inclusion criteria. Each participant will undergo a clinical exam and a lung ultrasound, which will assess eight zones of the lungs. The total number of B-lines-a sign of interstitial edema-will be documented. Data will be collected at three key times: upon admission, in the immediate postpartum period (within 24 hours of delivery), and 7-10 days postpartum. The results from the LUS will be compared to clinical signs like shortness of breath, rapid breathing, crackling sounds in the lungs, and oxygen saturation levels. The expected impact of this research is to provide evidence that LUS is a valuable, non-invasive, and accessible tool for the early detection of pulmonary congestion in patients with severe preeclampsia. This could lead to improved clinical decision-making and a reduction in maternal respiratory complications.

Who May Be Eligible (Plain English)

Who May Qualify: - Preeclampsia with severe features. - Gestational age 24 weeks - 41 weeks. Who Should NOT Join This Trial: - Chronic lung disease. - Known heart disease. - Diagnosis of lung edema at admission - Body mass index \> 40 - Need for immediate delivery Always talk to your doctor about whether this trial is right for you.

Original Eligibility Criteria

View original clinical language
Inclusion Criteria: * Preeclampsia with severe features. * Gestational age 24 weeks - 41 weeks. Exclusion Criteria: * Chronic lung disease. * Known heart disease. * Diagnosis of lung edema at admission * Body mass index \> 40 * Need for immediate delivery

Treatments Being Tested

DIAGNOSTIC_TEST

Lung ultrasound

Lung ultrasounf at three moments (at admission, before delivery and immediate post partum) to determine B Lines

Locations (1)

Saint Thomas Hospital
Panama City, Provincia de Panamá, Panama